Ramin Akhavan - Mar 23, 2022 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
General Counsel
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/25/2022, 08:09 PM
Previous filing
Jan 7, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Award $0 +59.1K +185.31% $0.00 91K Mar 23, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the restricted stock units shall vest on March 5, 2023 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in eight (8) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following March 5, 2023 until the final vesting date on March 5, 2025.
F2 Includes 660 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.